Company: IMRX
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001104659-25-088317
Chunk: 29

Company: Immuneering Corp
Filing Date: 2025-09-08
Form: 424B3
Chunk 29
---
, William Lipsey, John Goetz and Daren Tedeschi have voting and investment power over the shares held by ValueQuest Partners, LLC and may be deemed to beneficially own the shares held by ValueQuest Partners, LLC. The address of Value Quest Partners, LLC is 320 Park Ave., 7th Floor, New York, NY 10021.

(12)

Consists of (i) 253,164 shares of Common Stock, and (ii) 113,923 shares of Common Stock underlying the Purchase Warrant. The Purchase Warrant is subject to a beneficial ownership limitation of 4.99% of the outstanding shares of Common Stock, which such limitation restricts the Selling Securityholder from exercising that portion of the Purchase Warrant that would result in the Selling Securityholder, together with any of its affiliates or any person acting as a group therewith, beneficially owning, after exercise, a number of shares of Common Stock in excess of the beneficial ownership limitation.

<div align='center'>20</div>

TABLE OF CONTENTS

### PLAN OF DISTRIBUTION
Each Selling Stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell, transfer or otherwise dispose of any or all of their securities covered hereby on the Nasdaq Global Market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

•

ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

•

block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

•

purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

•

an exchange distribution in accordance with the rules of the applicable exchange;

•

privately negotiated transactions;

•

settlement of short sales;

•

in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;

•

through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

•

a combination of any such methods of sale; or

•

any other method permitted pursuant to applicable law.

The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act